Zietman A - Search Results

1

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Among authors: zietman a. Urology. 2001 Feb;57(2):225-9. doi: 10.1016/s0090-4295(00)00994-8. Urology. 2001. PMID: 11182325 Review. No abstract available.

2

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Among authors: zietman a. Urology. 2001 Feb;57(2):217-24. doi: 10.1016/s0090-4295(00)00993-6. Urology. 2001. PMID: 11182324 No abstract available.

3

Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years.

Preston MA, Feldman AS, Coen JJ, McDougal WS, Smith MR, Paly JJ, Carrasquillo R, Wu CL, Dahl DM, Barrisford GW, Blute ML, Zietman AI. Preston MA, et al. Among authors: zietman ai. Urol Oncol. 2015 Sep;33(9):383.e9-16. doi: 10.1016/j.urolonc.2015.04.015. Epub 2015 Jun 6. Urol Oncol. 2015. PMID: 26059076

4

Primary radiotherapy vs conservative management for localized prostate cancer--a population-based study.

Lu-Yao GL, Kim S, Moore DF, Shih W, Lin Y, DiPaola RS, Shen S, Zietman A, Yao SL. Lu-Yao GL, et al. Among authors: zietman a. Prostate Cancer Prostatic Dis. 2015 Dec;18(4):317-24. doi: 10.1038/pcan.2015.30. Epub 2015 Jun 23. Prostate Cancer Prostatic Dis. 2015. PMID: 26101187 Free PMC article.

5

Radioactive seeds for prostate cancer.

Zietman A. Zietman A. Health News. 1998 Oct 25;4(13):4-5. Health News. 1998. PMID: 9803172 No abstract available.

6

Current clinical trial design issues in hormone-refractory prostate carcinoma. Consensus Panel.

Vogelzang NJ, Crawford ED, Zietman A. Vogelzang NJ, et al. Among authors: zietman a. Cancer. 1998 Jun 1;82(11):2093-101. doi: 10.1002/(sici)1097-0142(19980601)82:11<2093::aid-cncr3>3.0.co;2-x. Cancer. 1998. PMID: 9610688 No abstract available.

7

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712.

Rana Z, Kamran SC, Shetty AC, Sutera P, Song Y, Bazyar S, Solanki AA, Simko JP, Pollack A, McConkey D, Kates M, Siddiqui MM, Hiken J, Earls J, Messina D, Mouw KW, Miyamoto D, Shipley WU, Michaelson MD, Zietman A, Coen JJ, Dahl DM, Jani AB, Souhami L, Chang BK, Lee RJ, Pham H, Marshall DT, Shen X, Pugh SL, Feng FY, Efstathiou JA, Tran PT, Deek MP. Rana Z, et al. Among authors: zietman a. Eur Urol Oncol. 2024 Apr 18:S2588-9311(24)00095-6. doi: 10.1016/j.euo.2024.03.015. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38641541

8

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.

Martin RM, Turner EL, Young GJ, Metcalfe C, Walsh EI, Lane JA, Sterne JAC, Noble S, Holding P, Ben-Shlomo Y, Williams NJ, Pashayan N, Bui MN, Albertsen PC, Seibert TM, Zietman AL, Oxley J, Adolfsson J, Mason MD, Davey Smith G, Neal DE, Hamdy FC, Donovan JL; CAP Trial Group. Martin RM, et al. Among authors: zietman al. JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011. Online ahead of print. JAMA. 2024. PMID: 38581198

9

A Multi-Institutional Survey of Radiation Oncology Professionals' Knowledge, Attitudes, and Practice Behaviors Toward Sexual and Gender Minority Patients With Cancer.

Gold B, Lei PJ, Kamran SC, Haas-Kogan DA, Franco I, Zietman AL, Smart AC, Wo JY. Gold B, et al. Among authors: zietman al. Adv Radiat Oncol. 2024 Feb 6;9(5):101461. doi: 10.1016/j.adro.2024.101461. eCollection 2024 May. Adv Radiat Oncol. 2024. PMID: 38550362 Free PMC article.

10

Recent Trends in "Manels" and Gender Representation Among Panelists at North American Annual Radiation Oncology Meetings.

Burgess L, Ghosh A, Yeap BY, Rasheed N, Ragala S, Nwiloh A, Willers H, Zietman A, Vapiwala N, Kamran SC. Burgess L, et al. Among authors: zietman a. Int J Radiat Oncol Biol Phys. 2024 Mar 18:S0360-3016(24)00434-6. doi: 10.1016/j.ijrobp.2024.03.018. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38508466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page